Phase 1 Bronchopulmonary Dysplasia Clinical Trials
8 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–8 of 8 trials
Recruiting
Phase 1
Pharmacokinetics and Placental Transfer of Caffeine
Apnea of PrematurityPremature BirthBronchopulmonary Dysplasia+2 more
Indiana University30 enrolled1 locationNCT07570121
Recruiting
Phase 1Phase 2
PK, Safety and Preliminary Efficacy Study of Montelukast in Critically Ill Infants With Developing Bronchopulmonary Dysplasia
Critical IllnessBronchopulmonary Dysplasia (BPD)Premature Births
Duke University28 enrolled5 locationsNCT07101640
Recruiting
Phase 1
Inhaled Ciclesonide Study in Preterm Infants
Bronchopulmonary Dysplasia
Venkatesh Sampath30 enrolled1 locationNCT06589245
Recruiting
Phase 1Phase 2
Safety and Efficacy of Umbilical Cord-derived Mesenchymal Stem Cell(MSC) Transplantation in the Treatment of Bronchopulmonary Dysplasia(BPD) in Premature Infants
BPD - Bronchopulmonary Dysplasia
The Children's Hospital of Zhejiang University School of Medicine10 enrolled1 locationNCT06788470
Recruiting
Phase 1Phase 2
Safety and Efficacy of MSC-EVs in the Prevention of BPD in Extremely Preterm Infants
Bronchopulmonary Dysplasia
EXO Biologics S.A.265 enrolled8 locationsNCT06279741
Recruiting
Phase 1Phase 2
Different Levels of BiPAP
Bronchopulmonary Dysplasia
King's College Hospital NHS Trust21 enrolled1 locationNCT06421519
Recruiting
Phase 1
Mesenchymal Stem Cells for Prevention of Bronchopulmonary Dysplasia in Infants
Bronchopulmonary Dysplasia
Meridigen Biotech Co., Ltd.9 enrolled1 locationNCT03631420
Recruiting
Phase 1
Human Amnion Epithelial Cells for Prevention of Bronchopulmonary Dysplasia in Preterm Infants: A Safety Study
Bronchopulmonary DysplasiaExtremely preterm birth
Monash Health24 enrolled2 locationsACTRN12618000920291